Envestnet Asset Management
RNLX

Envestnet Asset Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Envestnet Asset Management’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,858
Closed -$17.4K – 4197
2023
Q3 		$17.4K Buy
+10,858
New +$30K ﹤0.01% 3980
2023
Q2 		– Sell
-10,292
Closed -$24.9K – 4108
2023
Q1 		$24.9K Buy
+10,292
New +$28.5K ﹤0.01% 3912
2022
Q4 		– Sell
-17,288
Closed -$22K – 4097
2022
Q3 		$22K Buy
17,288
+325
+2% +$708 ﹤0.01% 3865
2022
Q2 		$42K Sell
16,963
-272
-2% -$1.29K ﹤0.01% 3831
2022
Q1 		$119K Buy
17,235
+3,126
+22% +$33.1K ﹤0.01% 3781
2021
Q4 		$224K Buy
+14,109
New +$282K ﹤0.01% 3599

Other funds holding RNLX

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Envestnet Asset Management's RNLX Position: Q4 2023 in Review

Envestnet Asset Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2023, closing a stake of 10,858 shares — an estimated $17.4K sold.

Envestnet Asset Management first reported a position in RNLX in Q4 2021 and held it in 6 quarters. The position peaked at $224K in Q4 2021. 27 funds tracked by Wall St. Rank hold RNLX as of Q4 2023.

  • Envestnet Asset Management reported no remaining Renalytix plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 10,858 Renalytix plc American Depositary Shares shares in Q4 2023, an estimated $17.4K.
  • Envestnet Asset Management first reported a position in Renalytix plc American Depositary Shares in Q4 2021 and held it in 6 quarters.
  • Envestnet Asset Management's Renalytix plc American Depositary Shares position peaked at $224K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2023.

Based on Envestnet Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.